PL365886A1 - Use of il-8 receptor antagonists in the treatment of virus infections - Google Patents

Use of il-8 receptor antagonists in the treatment of virus infections

Info

Publication number
PL365886A1
PL365886A1 PL01365886A PL36588601A PL365886A1 PL 365886 A1 PL365886 A1 PL 365886A1 PL 01365886 A PL01365886 A PL 01365886A PL 36588601 A PL36588601 A PL 36588601A PL 365886 A1 PL365886 A1 PL 365886A1
Authority
PL
Poland
Prior art keywords
treatment
receptor antagonists
virus infections
infections
virus
Prior art date
Application number
PL01365886A
Other languages
Polish (pl)
Inventor
Susan B. Dillon
Ruth Tal-Singer
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of PL365886A1 publication Critical patent/PL365886A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL01365886A 2000-07-18 2001-07-16 Use of il-8 receptor antagonists in the treatment of virus infections PL365886A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21905300P 2000-07-18 2000-07-18

Publications (1)

Publication Number Publication Date
PL365886A1 true PL365886A1 (en) 2005-01-10

Family

ID=22817645

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01365886A PL365886A1 (en) 2000-07-18 2001-07-16 Use of il-8 receptor antagonists in the treatment of virus infections

Country Status (17)

Country Link
EP (1) EP1307190A4 (en)
JP (1) JP2004509852A (en)
KR (1) KR20030019587A (en)
CN (1) CN1449285A (en)
AR (1) AR033830A1 (en)
AU (1) AU2001273497A1 (en)
BR (1) BR0112603A (en)
CA (1) CA2418162A1 (en)
CZ (1) CZ2003132A3 (en)
HU (1) HUP0300754A3 (en)
IL (1) IL153921A0 (en)
MX (1) MXPA03000500A (en)
NO (1) NO20030201L (en)
NZ (1) NZ523659A (en)
PL (1) PL365886A1 (en)
WO (1) WO2002005814A1 (en)
ZA (1) ZA200300474B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007001561A (en) * 2004-08-04 2007-04-16 Schering Corp Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases.
US20170100385A1 (en) * 2014-05-12 2017-04-13 Glaxosmithkline Intellectual Property (No. 2) Limited Pharmaceutical compositions comprising danirixin for treating infectious diseases
CA3176715A1 (en) * 2020-03-26 2021-09-30 Dompe' Farmaceutici Spa Cxcl8 inhibitors for use in the treatment of covid-19
EP4008325A1 (en) * 2020-12-02 2022-06-08 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19
EP3884932A1 (en) * 2020-03-26 2021-09-29 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547979A (en) * 1992-03-30 1996-08-20 Smithkline Beecham TNF inhibition
WO1996005836A2 (en) * 1994-08-25 1996-02-29 Medical University Of South Carolina Methods of treating cold symptoms using pentoxifylline
JPH11503110A (en) * 1995-02-17 1999-03-23 スミスクライン・ビーチャム・コーポレイション IL-8 receptor antagonist
SE9802729D0 (en) * 1998-08-13 1998-08-13 Astra Pharma Prod Novel Compounds
SE9802937D0 (en) * 1998-09-01 1998-09-01 Astra Pharma Prod Novel compounds

Also Published As

Publication number Publication date
AR033830A1 (en) 2004-01-07
HUP0300754A2 (en) 2003-08-28
AU2001273497A1 (en) 2002-01-30
CA2418162A1 (en) 2002-01-24
NO20030201L (en) 2003-03-17
CN1449285A (en) 2003-10-15
KR20030019587A (en) 2003-03-06
WO2002005814A1 (en) 2002-01-24
ZA200300474B (en) 2004-08-17
NO20030201D0 (en) 2003-01-15
EP1307190A1 (en) 2003-05-07
JP2004509852A (en) 2004-04-02
EP1307190A4 (en) 2007-08-22
IL153921A0 (en) 2003-07-31
NZ523659A (en) 2006-01-27
MXPA03000500A (en) 2003-06-24
HUP0300754A3 (en) 2009-03-02
CZ2003132A3 (en) 2003-09-17
BR0112603A (en) 2004-08-24

Similar Documents

Publication Publication Date Title
EE05507B1 (en) Use of rosuvastatin ZD4522) in the treatment of heterosgococcal family h percolesterolemia
MXPA03004915A (en) Mch antagonists and their use in the treatment of obesity.
MXPA03008501A (en) Mch antagonists and their use in the treatment of obesity.
HUS1300015I1 (en) Antibodies to human il-1beta
EE200200484A (en) Low dose entecavir preparation and its use
DE60124863D1 (en) AGAINST HUMAN INTERLEUKIN-1-BETA RECOMBINANT ANTIBODIES
IL141034A0 (en) Uracil compounds and use thereof
PT1317485E (en) Myostatin antagonists and uses thereof
DE60033055D1 (en) LUMBAR TREATMENT DEVICE
MXPA03004439A (en) Aminothiazoles and their use as adenosine receptor antagonists.
DE60135144D1 (en) Interconnects
HUP0301308A3 (en) Human papilloma virus treatment
DE60026949D1 (en) Interconnects
IL153708A0 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
AR027945A1 (en) USE OF PRAMIPEXOL IN THE TREATMENT OF ADDICTION DISORDERS
HUP0300599A3 (en) Il-8 receptor antagonists, pharmaceutical compositions containing them and their use
DE60119875D1 (en) Interconnects
AU9279601A (en) Compounds and methods for use thereof in the treatment of cancer or viral infections
SI1556382T1 (en) 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof
DE60106146D1 (en) Interconnects
DE60112673D1 (en) Interconnects
DE60107134D1 (en) Interconnects
DE60100973D1 (en) Interconnects
HUP0300754A3 (en) Use of il-8 receptor antagonists in the treatment of virus infections
HUP0300470A3 (en) Il-8 receptor antagonists, pharmaceutical compositions containing them and their use

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)